Imidazole salicylate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C7H6O3.C3H4N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4JVD4X01MJ, chemically known as salicylic acid, compound with imidazole (1:1) but generally known as imidazole salicylate, which bears US NIH Compound Identifier 37425. European Medicines Agency schedules Imidazole salicylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08145MIG. The term IMIDAZOLE SALICYLATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules imidazole salicylate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule imidazole salicylate under HS 29332990 and SITC 51573. As of Q4 2014, IMIDAZOLE SALICYLATE remains the US FDA Preferred Term for this commodity. Imidazole salicylate bears US NLM identifiers UMLS ID C0063384 and NCI Concept Code C65894. SMILES: C1=CC=C(C(=C1)C(=O)O)O.C1=CN=CN1.